What is AVTR's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 10.60B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for AVTR?

P/E (TTM) is n/a and 52-week range is $7.26 to $16.38 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s AVTR figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for AVTR?

The company profile lists revenue (TTM) near $6.55B, net income (TTM) near $-57.73B, EPS (TTM) near $-0.85 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Avantor Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Radnor, Pennsylvania, US, 676.4M shares outstanding, ISIN US05352A1007 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Avantor Inc

$AVTR

Health Care · Life Sciences Tools & Services

IR Run Scenarios

$15.67

+1.82%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

Employees

13,500

Website

www.avantorsciences.com/

IPO

2019-05-17

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)